Purpose:

At Tampa General Hospital (TGH) Transplant Institute, we are committed to enhancing patient care and expanding access to transplants for all individuals. As part of this commitment, we are proud to introduce the African American Transplant Access Program (AATAP). AATAP is designed to address and reduce health disparities by breaking down barriers that have historically made it more difficult for Black patients to be placed on the kidney transplant waiting list.

Selection:

The African American Transplant Access Program (AATAP) is a randomized clinical trial funded by the National Institutes of Health (NIH). Participation is limited to individuals who meet specific eligibility criteria. If you qualify, you will be randomly assigned to one of two groups: the standard care group or the AATAP group. The standard care group will follow the usual evaluation process that all patients currently undergo. If you are placed in the AATAP group, your care will be managed by a team of providers who share your ethnic background and understand your unique needs. The insights gained from this study will be essential in improving access to kidney transplants for the Black community, both in the Tampa Bay area and nationwide.

Study Group:

As a participant in the African American Transplant Access Program (AATAP), you will be asked to complete surveys at the start of the study and again after 12 months. These surveys will collect basic demographic information and explore topics such as your socioeconomic status, health literacy, and social support. A small stipend will be provided upon their completion.

If you are successfully placed on the kidney transplant waiting list, your follow-up care will continue as it does for all patients until you receive a transplant.

For more information, please contact:

Michael Malcom

Research Coordinator

813-660-6707

mmalcolm@tgh.org